Press Releases

Capital Rx Makes the 2025 Inc. 5000, Celebrating Four Consecutive Years Among America’s Fastest-Growing Private Companies

August 12, 2025

NEW YORK, August 12, 2025 – Capital Rx, Inc., the enterprise health technology company and benefit administrator, today announced that it has ranked No. 955 on the 2025 Inc. 5000 list. This is the fourth straight year Capital Rx has appeared on the list, an achievement underscoring the market’s demand for next-generation enterprise health technology like Judi® and independent, transparent pharmacy benefit administration solutions.  

“At Capital Rx, we’re building the foundation and tools needed to power the future of healthcare administration,” said Co-Founder & CEO AJ Loiacono. “Employers, health plans, and patients deserve visibility into costs and improved access to care. Achieving our fourth consecutive recognition on the Inc. 5000 is a testament to both the need for our modern, flexible solutions and their unparalleled efficacy.”

With the recent acquisition of Amino Health – now Judi Care - and its AI-powered care navigation platform, Capital Rx offers a truly unique, unified healthcare experience to plan sponsors and members alike. This is in addition to Judi Health™, the first unified claims processing platform in the U.S., which is capable of processing pharmacy, medical, dental, and vision claims.

“Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company’s tenacity and clarity of vision,” says Mike Hofman, editor-in-chief of Inc. “These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn’t just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.”

This year’s Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years.

For the full list, company profiles, and a searchable database by industry and location, visit: www.inc.com/inc5000.

Methodology

Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

About Capital Rx  

Capital Rx is a health technology company providing comprehensive full-service health benefit solutions to carriers, health plans, TPAs, employer groups, and government entities. As a public benefit corporation, Capital Rx is executing its mission to reduce healthcare costs as a pharmacy benefit administrator and by deploying Judi®, the company’s cloud-native enterprise health platform. Together with its clients, Capital Rx is reimagining the administration of benefits and rebuilding trust in the healthcare industry. To learn more, visit www.capitalrx.com.

Media Contacts

Michael Passanante, SVP, Marketing & Communications

Justin Venneri, Senior Director, Communications

marketing@cap-rx.com

 

Alex Jenkins, 120/80 Group

CapitalRx@12080group.com

DOWNLOAD NOWBack to Insights

Sign up for our newsletter!

Get the latest information on Judi news, webinars, and industry insights through our newsletter. Sign up now!